Goffart et al. [50], as well as Hattermann et al. [28] associated the CXCL12-CXCR4 signaling axis with an increased resistance of GBM stem cells, and CCL2 expression correlated with the progression of GBMs [51–54]. Here, CCL2 is linked to glioblastoma.